Pharmacologic treatment of congenital nystagmus.
Sarvananthan
N
N
Department of Ophthalmology, Faculty of Medicine and Biological Sciences, The Leicester Royal Infirmary, England. nagini@pathmanathan.com
Proudlock
F A
FA
Choudhuri
I
I
Dua
H
H
Gottlob
I
I
D000284:Administration, Oral; D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005133:Eye Movements; D000077206:Gabapentin; D006801:Humans; D008297:Male; D020417:Nystagmus, Congenital / Q000188:drug therapy*; D014792:Visual Acuity; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin